Inhibition of the Interaction between HIV-1 Integrase and its Cofactor LEDGF/p75: A Promising Approach in Anti-Retroviral Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|11|8|714-727

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.11, Iss.8, 2011-07, pp. : 714-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Development of Small-Molecular Inhibitors Target HIV Integrase-LEDGF/p75 Interaction

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 14, 2015-12 ,pp. : 1195-1208

Bentham Science Publishers

Access to resources Recommend Favorite

Adherence to Anti-Retroviral Therapy and Its Determinants in HIV/AIDS Patients: A Review

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 5, 2012-10 ,pp. : 346-356

Bentham Science Publishers

Access to resources Recommend Favorite

The Effectiveness of Anti-retroviral Drug Therapy for HIV-1 Is Associated with HIV-1 Proviral DNA Levels and Viral Selection

By Ariyama I   Chong Y   Murata M   Nabeshima S   Ikematsu H   Kashiwagi S   Hayashi J  

The Journal of International Medical Research, Vol. 30, Iss. 3, 2002-05 ,pp. : 289-300

Field House Publishing

Access to resources Recommend Favorite

Fragment Based Approach for the Investigation of HIV-1 Integrase Inhibition

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 2, 2007-03 ,pp. : 99-105

Bentham Science Publishers

Access to resources Recommend Favorite

Novel integrase inhibitor promising in triple-class resistant HIV-1

By  

Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite